Navigation Links
New data suggest 'jumping genes' play a significant role in gene regulatory networks
Date:2/14/2009

CHICAGO, IL--Research performed in the Center for Biomolecular Science & Engineering (CBSE) at the University of California, Santa Cruz, suggests that mobile repetitive elements--also known as transposons or "jumping genes"--do indeed affect the evolution of gene regulatory networks.

David Haussler, CBSE director and distinguished professor of biomolecular engineering at UCSC's Jack Baskin School of Engineering, said CBSE research teams are finding evidence that the early theories of Nobel Prize winner Barbara McClintock, later modeled by Roy Britten and Eric Davidson, are correct. Haussler will discuss these findings in a presentation on "Transposon-induced rewriting of vertebrate gene regulation" at the annual meeting of the American Association for the Advancement of Science (AAAS) in Chicago.

"Comparison of the human genome with the genomes of other species reveals that at least five percent of the human genome has been under negative selection during most of mammalian evolution," Haussler said. "We believe that this five percent is, therefore, likely to be functional."

Coding exons and structural RNA genes stand out because of their distinctive pattern of base substitutions and "indels"--the insertions and deletions of nucleic acid bases that can change the message in a genome. According to Haussler, however, most of the DNA under negative selection in vertebrate genomes does not appear to be transcribed and shares no sequence similarity with the genomes of invertebrates.

"Our research suggests that many of these elements serve as distal enhancers for developmental genes," Haussler said. "A significant amount of the gene regulatory material appears to have indeed been put into place by ancient transposons."


'/>"/>

Contact: Mary Trigiani
mtrigiani@soe.ucsc.edu
831-459-4495
University of California - Santa Cruz
Source:Eurekalert

Page: 1

Related biology news :

1. New lab evidence suggests preventive effect of herbal supplement in prostate cancer
2. Cancer-causing gene discovery suggests new therapies
3. Mayo Clinic: Brain disorder suggests common mechanism may underlie many neurodegenerative diseases
4. Recipe for capturing authentic embryonic stem cells may apply to any mammal, study suggests
5. Purdue study suggests warmer temperatures could lead to a boom in corn pests
6. Discovery of new gene associated with diabetes risk suggests link with body clock
7. Shrimp trawling may boost mercury in red snapper, study suggests
8. Revised theory suggests carbon dioxide levels already in danger zone
9. Seasonal affective disorder may be linked to genetic mutation, study suggests
10. NJIT professors research suggests changes in underwater data communications
11. Atomic-resolution views suggest function of enzyme that regulates light-detecting signals in eye
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/8/2017)... BEDFORD, Mass., Feb. 7, 2017  Aware, Inc. (NASDAQ: ... services, today reported financial results for its quarter and year ... fourth quarter of 2016 was $3.9 million compared to $6.9 ... the fourth quarter of 2016 was $0.6 million compared to ... in the fourth quarter of 2016 was $0.5 million, or ...
(Date:2/8/2017)... , Feb. 7, 2017 Report Highlights ... by 2021 from $8.3 billion in 2016 at a ... to 2021. Report Includes - An overview of ... market trends, with data from 2015 and 2016, and ... - Segmentation of the market on the basis of ...
(Date:2/7/2017)... , February 7, 2017 ... Global Solutions Corporation [OTC: IDGS], ("Ipsidy" or the "Company") ... electronic transaction processing services, is pleased to announce the ... Company. Effective January 31, 2017, Philip ... of Directors, CEO and President.  An experienced payment industry ...
Breaking Biology News(10 mins):
(Date:2/24/2017)... 24, 2017 Symic Bio, a biopharmaceutical company ... category of therapeutics, announced today the completion of enrollment ... artery disease. The trial will evaluate the safety and ... the reduction of restenosis following angioplasty. ... for SB-030," said Nathan Bachtell , M.D., Chief ...
(Date:2/24/2017)... Feb. 24, 2017 China Cord Blood Corporation (NYSE: ... leading provider of cord blood collection, laboratory testing, hematopoietic ... announced its unaudited financial results for the third quarter ... December 31, 2016. Third Quarter of Fiscal ... quarter of fiscal 2017 increased by 18.6% to RMB200.9 ...
(Date:2/24/2017)... Products, Inc. (NASDAQ: CBPO) ("China Biologic" or the "Company"), a ... its financial results for the fourth quarter and fiscal year ... Total sales in the fourth quarter ... by 13.6% in USD terms to $77.6 million from $68.3 ... Gross profit increased by 13.3% to $46.8 million from $41.3 ...
(Date:2/24/2017)...  OncoSec Medical Incorporated ("OncoSec") (NASDAQ: ONCS), a company ... Opinion Leader event to highlight new clinical data that ... at the upcoming 2017 ASCO-SITC Immuno-Oncology Symposium and the ... held in-person and via live webcast on Tuesday, February ... at the Lotte New York Palace Hotel in ...
Breaking Biology Technology: